Elke Schäffeler

1.6k total citations · 1 hit paper
6 papers, 1.2k citations indexed

About

Elke Schäffeler is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Genetics. According to data from OpenAlex, Elke Schäffeler has authored 6 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pediatrics, Perinatology and Child Health, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in Elke Schäffeler's work include Drug Transport and Resistance Mechanisms (3 papers), Hemoglobinopathies and Related Disorders (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Elke Schäffeler is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Hemoglobinopathies and Related Disorders (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Elke Schäffeler collaborates with scholars based in Germany, France and United States. Elke Schäffeler's co-authors include Matthias Schwab, Eduard F. Stange, Michael Weichenthal, Miriam Schlee, Péter Fritz, K Herrlinger, Jan Wehkamp, Florian Noack, Jürgen Harder and Charles Bevins and has published in prestigious journals such as Gut, Thrombosis Research and Journal of Proteomics.

In The Last Decade

Elke Schäffeler

6 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression

2004 618 citations Jan Wehkamp, Jürgen Harder et al. Gut profile →

Peers

Countries citing papers authored by Elke Schäffeler

Since Specialization

Citations

This map shows the geographic impact of Elke Schäffeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke Schäffeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke Schäffeler more than expected).

Fields of papers citing papers by Elke Schäffeler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elke Schäffeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke Schäffeler. The network helps show where Elke Schäffeler may publish in the future.

Co-authorship network of co-authors of Elke Schäffeler

This figure shows the co-authorship network connecting the top 25 collaborators of Elke Schäffeler. A scholar is included among the top collaborators of Elke Schäffeler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elke Schäffeler. Elke Schäffeler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Impact of point-of-care testing for CYP2C19 on platelet inhibition in patients with acute coronary syndrome and early dual antiplatelet therapy in the emergency setting 2014 ·Thrombosis Research ·Fabian Stimpfle, Athanasios Karathanos, Michal Droppa, (unknown), Dominik Rath, Karin Müller, (unknown), Elke Schäffeler, Stefan Winter, Matthias Schwab, Meinrad Gawaz, Tobias Geisler	18
2	MALDI-TOF mass spectrometry screening of cholelithiasis risk markers in the gene of HNF1alpha 2012 ·Journal of Proteomics ·(unknown), (unknown), (unknown), (unknown), (unknown), Olga Renner, Oliver J. Müller, Elke Schäffeler, Wolfgang Kratzer, Matthias Schwab, Eduard F. Stange	4
3	GSTP1 and MDR1 Genotypes and Central Nervous System Relapse in Childhood Acute Lymphoblastic Leukemia 2005 ·International Journal of Hematology ·Martin Stanulla, Elke Schäffeler, (unknown), (unknown), André Schrauder, Karl Welte, (unknown), Ulrich M. Zanger, Martin Schrappe, Matthias Schwab	40
4	NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression breakdown → 2004 ·Gut ·Jan Wehkamp, Jürgen Harder, Michael Weichenthal, Matthias Schwab, Elke Schäffeler, Miriam Schlee, K Herrlinger, Andreas Stallmach, Florian Noack, Péter Fritz, J.‐M. Schröder, Charles Bevins, Klaus Fellermann, Eduard F. Stange	618
5	Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism. 2002 ·Pharmacogenetics ·Matthias Schwab, Elke Schäffeler, Claudia Marx, Christine Fischer, Thomas Lang, Christoph Behrens, Michael Gregor, Michel Eichelbaum, (unknown), Bernd Kaskas	201
6	The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells 2001 ·Pharmacogenetics ·Monika Hitzl, Siegfried Drescher, Heiko van der Kuip, Elke Schäffeler, Joachim E. Fischer, Matthias Schwab, Michel Eichelbaum, Martin F. Fromm	318

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact